Diagnostic and prognostic procedure for chronic kidney disease in a human subject

Developed by: Instituto de Investigación Sanitaria Fundación Jiménez Díaz

Description

Description

Method for diagnosis and prognosis of chronic kidney disease and associated heart disease

Applications

Diagnosis and prognosis of chronic kidney disease and risk of cardiovascular events in these patients determined by measuring concentrations of at least one of the following in an isolated sample obtained from a patient: 5-oxoproline, glutamate, guanidinoacetate, alpha-phenylacetylglutamine, taurine, trimethylamine N-oxide (TMNO), homocysteine, leucine, threonine, and citrate; additionally, the result will be assessed by comparing the values from these measurements against those of a reference group of healthy subjects.

Protection status

National patent. Spanish Patent and Trademark Office.

Cooperation requested

Search for licensees for the patent

Search for partners to undertake joint development of the technology

Therapy Area

Nephrology

Cardiology

Technology Area

Biotechnology and molecular diagnosis

Status:
N/A
Health technology:
N/A